IL6 and inflammatory bowel disease: Yang et al. [67] reported that IL-6 overpasses the suppressive effect of Foxp3 on RORγt and, together with IL-23 [71], can reprogram fully differentiated Treg cells towards the Th17 lineage, both in murine models and human IBD.